Wegovy's list price is approximately $1,349 per month without insurance. That number stops most people immediately. But the actual out-of-pocket cost for many patients is significantly lower — if you know how the system works. Here is what actually reduces your cost, in order of effectiveness.

1. NovoCare® Savings Program (Most Impactful)

Novo Nordisk's NovoCare program has two components people confuse:

Apply at novonordisk-us.com/products/novocare. The eligibility check takes about 10 minutes. Your physician must be enrolled in the prescribing program.

2. LillyDirect™ for Zepbound (Alternative to Wegovy)

If Wegovy specifically isn't required (and for most patients it isn't — tirzepatide often achieves greater weight loss per the SURMOUNT trials), Zepbound (tirzepatide) through LillyDirect™ is now available at:

These are cash prices without insurance. For context, Zepbound at 5 mg via LillyDirect™ ($499/month) is less expensive than Wegovy at 1 mg through a traditional pharmacy without coverage. LillyDirect™ handles dispensing directly — your YourMD physician writes the prescription to LillyDirect™.

3. GoodRx and Discount Cards (Limited Impact for GLP-1s)

GoodRx coupons typically reduce Wegovy cost to $1,100–$1,200/month — meaningful but not transformative. These coupons cannot be combined with insurance. If your insurance covers even a portion of Wegovy, use your insurance rather than GoodRx (GoodRx use doesn't count toward your deductible). GoodRx is most useful for generic medications where discounts are substantial; branded GLP-1s have limited room to discount.

4. YourMD Membership Structure ($79/Month + Medication)

YourMD's GLP-1 Essential plan is $79/month for the physician consultation, monitoring, and prescription management. The medication is billed separately directly through NovoCare® or LillyDirect™. This means:

The $79 covers real physician oversight — not an async questionnaire. Monthly check-ins, labs review, dosing adjustments, side effect management, and prior authorization support if you need it.

5. Compounded Semaglutide: The Current Status (Mid-2026)

During the FDA shortage period (2022–2024), compounded semaglutide from 503A pharmacies was legal and widely used. As Novo Nordisk restored supply, the FDA removed semaglutide from the shortage list. The FDA has stated that 503A compounding of commercially available drugs (where the commercial version is not on shortage) raises legal questions under the FD&C Act.

The situation is actively evolving — FDA enforcement, court decisions, and state pharmacy board positions vary as of mid-2026. Before pursuing compounded semaglutide, verify the current FDA shortage list status and confirm your compounding pharmacy is operating within current guidance. YourMD does not compound semaglutide or tirzepatide — we prescribe FDA-approved branded medications only.

See our detailed article: Compounded Semaglutide Safety.

6. Open Enrollment: Plan Selection Strategy

If you know you will need GLP-1 therapy for the coming year, the highest-ROI decision is choosing a health plan during open enrollment that covers Wegovy or Zepbound. A plan with $200 higher monthly premium that covers Wegovy is better value than a cheaper plan where Wegovy costs $1,349/month out of pocket. Most large employer HR departments can tell you which formulary tiers include GLP-1 medications. Ask specifically — "Does the plan formulary cover Wegovy (semaglutide 2.4 mg) for chronic weight management?"

The Bottom Line

The most cost-effective path for most patients: (1) get a physician evaluation to confirm eligibility, (2) check NovoCare or LillyDirect™ eligibility, (3) if cost is still prohibitive, request a PA and use your physician to appeal denials. YourMD physicians handle this workflow regularly. The $79/month membership quickly pays for itself if a successful PA saves you $1,200+/month on medication.